等待開盤 09-30 09:30:00 美东时间
+2.280
+6.25%
4 analysts have expressed a variety of opinions on Kiniksa Pharmaceuticals (NASDAQ: KNSA) over the past quarter, offering a diverse set of opinions from bullish to bearish.
今天 02:01
今日重点评级关注:Ascendiant Capital:维持Aytu BioPharma"买入"评级,目标价从12美元升至12.5美元;Oppenheimer:维持Immuneering"跑赢大市"评级,目标价从21美元升至30美元
09-26 09:45
Wells Fargo analyst Eva Fortea Verdejo maintains Kiniksa Pharmaceuticals (NASDAQ: KNSA) with a Overweight and raises the price target from $42 to $45.
09-25 21:36
Kiniksa Pharmaceuticals ( ($KNSA) ) has shared an update. On September 3, 2025,...
09-03 19:57
Kymera Therapeutics (NASDAQ:KYMR) is gearing up to announce its quarterly earni...
08-08 23:01
Recursion Pharmaceuticals (NASDAQ:RXRX) is gearing up to announce its quarterly...
08-05 01:05
Shares of CommScope Holding Company, Inc. (NASDAQ:COMM) rose sharply in pre-mar...
08-04 18:55
今日重点评级关注:花旗:维持Apellis Pharmaceuticals"买入"评级,目标价从41美元升至46美元;杰富瑞:维持Kiniksa Pharmaceuticals"买入"评级,目标价从45美元升至54美元
07-30 09:36
Kiniksa Pharmaceuticals Ltd. Class A (($KNSA)) has held its Q2 earnings call. R...
07-30 08:38
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is projected to repor...
07-29 16:32